Table 1 Clinical characteristics of study population (n = 80), risk factors and comorbidities.
From: MicroRNAs distribution in different phenotypes of Aortic Stenosis
Gender (Male) | 34 | 42% |
Age (years) | 81 | 76.7–84.0 |
Weight (Kg) | 73 | 69.8–75.3 |
Height (cm) | 164 | 164.2–167.9 |
BMI (kg/m2) | 26 | 25.5–27.1 |
BSA (m2) | 1.8 | 1.78–1.86 |
SAP (mmHg) | 137.6 | 133–141 |
DAP (mmHg) | 71.5 | 68–74 |
Smokers | 11 | 13.6% |
Family history of cerebro-vascular disease | 18 | 22.2% |
Diabetes Mellitus | 21 | 25.9% |
Hypertension | 70 | 86.4% |
Dyslipidaemia | 11 | 13.6% |
Obesity | 16 | 19.7% |
History of Angina | 24 | 29.6% |
CAD (<50% Epicardial Vessels) | 35 | 43.2% |
COPD | 18 | 22.2% |
NYHA class I/II | 48 | 59.3% |
NYHA class >II | 33 | 40.7% |
Syncope | 9 | 11.1% |
Atrial Fibrillation | 9 | 11.1% |
eGFR (mL/min/1.73 m2) | 58.667 | 46.4–76.1 |
CKD | 46 | 56.8% |
Anaemia | 18 | 22.2% |
White Blood Cells (103/µL) | 8 | 5–10.5 |
Erythrocytes (106/µL) | 4 | 3.5–6 |
Platelets (103/µL) | 180 | 140–230 |
EuroSCORE II (%) | 2.6 | 1.7–4.0 |
Logistic EuroSCORE (%) | 8.38 | 4.7–15.1 |
